Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma
Clinical trial NCT00287222 · COMPLETED
Trial details
- NCT number
- NCT00287222
- Sponsor
- University of Arkansas
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2010-09-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.